Hazel Zeynep KOCABAŞ, Ebru Özkan KARACA, Gizem İnce KUKA, Ogül Leman TUNAR, Hare GÜRSOY

Kardiyovasküler hastalık periodontal sağlık ilişkisi

Koroner kalp hastalıkları ve inme (serebrovasküler sistemin daralma, blokaj veya hemorajisi) dünyada ölüme sebep olan nedenlerin başında gelmektedir. Kardiyovasküler hastalıkların (KVH) bir parçası olan atereskleroz, gelişmiş ülkelerdeki ölümlerin başlıca nedenidir. Yapılan çalışmalar, hipertansiyon, yüksek kolesterol, sigara gibi KVH oluşumunda risk faktörleri olarak bilinen durumların kontrol altına alınmasının mortaliteyi azalttığını göstermesine rağmen dünyada KVH'ye bağlı ölümler giderek çoğalmaktadır. Bilinen risk faktörleri dışında, iltihaplanmanın KVH gelişiminde önemli bir rol oynadığına dair yeni kanıtların olması, tüm dünyada yaygın olarak görülen kronik iltihabi bir hastalık olan periodontitisin, KVH'nin ilerlemesine katkıda bulunan sebeplerden biri olabileceğinin öne sürülmesine neden olmuştur. Bu derlemede amaç, periodontal hastalık ile KVH arasındaki ilişkinin; güncel bilgiler ışığında gözden geçirilmesi, periodontal hastalığın yeterince dikkate alınmaması ve KVH riski altındaki yetişkinlerde oldukça yaygın olarak görülmesinden dolayı aralarındaki ilişkiyi incelemektir

Interaction between cardiovascular disease and periodontal health

Coronary heart disease and stroke (constriction, blockage or hemorrhage of the cerebrovascular system) are the leading causes of death in the world. Atherosclerosis, a part of cardiovascular disease (CVD), is the major cause of death in developed countries. Although controlling conditions known as risk factors for CVD, such as hypertension, high cholesterol, and smoking reduces mortality, CVD-related deaths are increasing. Apart from known risk factors, periodontitis, a chronic inflammatory disease that is widespread throughout the world, has been suggested to be one of the associated factor for CVD progress. The purpose of this review is to highlight the relationship between periodontal disease and CVD in the light of current literature, since periodontal disease is not adequately addressed and it is quite common in adults at risk for CVD

PDF

___

1. Luepker RV. Cardiovascular disease: rise, fall, and future prospects. Annu Rev Public Health 2011; 32: 1-3.
2. Nabel EG. Cardiovascular disease. N Engl J Med 2003; 349: 60-72.
3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet. 2006; 367: 1747-1757.
4. Külekçi G. Diş Hekimliğinde Kardiyovasküler Hastalik Risk Değerlendirmesi. Ankem Derg 2011; 25: 70-76.
5. Law MR, Morris J, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 1997; 315: 973-980.
6. He J, et al. Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies. New Engl J Med 1999; 340: 920-926.
7. Kallio K, et al. Arterial intima-media thickness, endothelial function, and apolipoproteins in adolescents frequently exposed to tobacco smoke. Circ Cardiovasc Qual Outcomes 2010; 3: 196-203.
8. Strazzullo P, D’Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009; 339
9. Austin MA. Epidemiology of hypertriglyceridemia and cardiovascular disease. The Am J Cardio 1999; 83:13-16.
10. Li C, et al. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis. Cochrane Database Syst Rev. 2014 15; CD009197. doi: 10.1002/14651858.CD009197.pub2.
11. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014; 35: 2950-2959.
12. Kjellström B, Rydén L, Klinge B, Norhammar A. Periodontal disease–important to consider in cardiovascular disease prevention. Expert Rev Cardiovasc Ther 2016 ;14: 987-989.
13. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 2002; 8:1257-1262.
14. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
15. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995; 57: 791-804.
16. Mattila KJ, et al. Association between dental health and acute myocardial infarction. BMJ 1989; 298: 779- 781.
17. Simonka M, Skaleric U, Hojs D. Condition of teeth andperiodontal tissue in patients who had suffered a heart attack. Zobozdrav Vestn 1988; 43: 81-83.
18. Hueb W, et al. Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial. Circulation 2010; 122: S48-52.
19. Hansson GK. Inflammation and immune response in atherosclerosis. Curr Atheroscler Rep 1999;1 : 150-155.
20.Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366: 1809-1820.
21. Socransky S, Haffajee A, Cugini M, Smith C, Kent R. Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25: 134-144.
22. Schenkein HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Clin Periodontol 2013; 40: S51-69.
23. Paulson KE, Zhu S-N, Chen M, Nurmohamed S, Jongstra-Bilen J, Cybulsky MI. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res 2010; 106: 383-930.
24. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13: 547-558.
25. Gaetti-Jardim Jr E, et al. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 2009; 58: 1568-1575.
26. Figuero E, et al. Detection of periodontal bacteria in atheromatous plaque by nested polymerase chain reaction. J Periodontol; 2011; 82: 1469-1477.
27. Spahr A, et al. Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med 2006; 166: 554-559.
28. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007; 154: 830-837.
29. Arbes Jr SJ, Slade G, Beck J. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 1999; 78: 1777-1782.
30. Janket S-J, Baird AE, Chuang S-K, Jones JA. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 95: 559-569.
31. Mattila KJ, et al. Age, dental infections, and coronary heart disease. J Dent Res 2000; 79: 756-760.
32. Collaboration ERF. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-140.
33. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
34. Ridker PM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
35. Lerman A, McConnell JP. Lipoprotein-associated phospholipase A 2: a risk marker or a risk factor? Am J Cardiol 2008; 101: 11-22.
36. Söder PÖ, Meurman J, Jogestrand T, Nowak J, Söder B. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. J Periodontal Res 2009; 44: 452-458.
37. Heslop CL, Frohlich JJ, Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 2010; 55: 1102-1109.
38. Green D, Foiles N, Chan C, Schreiner PJ, Liu K. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study. Atherosclerosis 2009; 202: 623-631.
39. Danesh J, et al. Fibrinogen Studies Collaboration: Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005; 294: 1799-1809.
40. Loos BG, et al. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000; 71: 1528-1534.
41. Noack B, et al. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227.
42. Ebersole JL, et al. Periodontitis in humans and non-human primates: oral-systemic linkage inducing acute phase proteins. Ann Periodontol 2002; 7: 102-111.
43. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol 2005; 76: 2106-2115.
44. Chun YHP, Chun KRJ, Olguin DA, Wang HL. Biological foundation for periodontitis as a potential risk factor for atherosclerosis. J Periodontal Res 2005; 40: 87-95.
45. Paquette DW. The periodontal-cardiovascular link. Compend Contin Educ Dent 2004; 25: 681-682.
46. Offenbacher S, Elter JR, Lin D, Beck JD. Evidence for periodontitis as a tertiary vascular infection. J Int Acad Periodontol 2005; 7: 39-48.
47. Maekawa T, Tabeta K, Kajita-Okui K, Nakajima T, Yamazaki K. Increased expression of C-reactive protein gene in inflamed gingival tissues could be derived from endothelial cells stimulated with interleukin-6. Arch Oral Biol 2011; 56: 1312-1318.
48. Lu Q, Jin L. Human gingiva is another site of C-reactive protein formation. J Clin Periodontol 2010; 37: 789- 796.
49. Kohm AP, Fuller KG, Miller SD. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol 2003; 11: 101-105.
50. Pussinen PJ, Mattila K. Periodontal infections and atherosclerosis: mere associations? Curr Opin Lipidol 2004; 15: 583-588.
51. Seymour G, Ford P, Cullinan M, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease. Clin Microbiol Infec 2007; 13: 3-10.
52. Lockhart PB, et al. Poor oral hygiene as a risk factor for infective endocarditis–related bacteremia. J Am Dent Assoc 2009; 140: 1238-1244.
53. Lockhart PB, et al. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008; 117: 3118-3125.
54. Bahrani-Mougeot FK, et al. Diverse and novel oral bacterial species in blood following dental procedures. J Clin Microbiol 2008; 46: 2129-2132.
55. Bayliss R, et al. The microbiology and pathogenesis of infective endocarditis. Br Heart J 1983; 50: 513-519.
56. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands: I. Patient characteristics. Arch Intern Med 1992; 152: 1863-1868.
57. Strom BL, et al. Dental and cardiac risk factors for infective endocarditis: a population-based, case-control study. Ann Internal Med 1998; 129: 761-769.
58. Hujoel PP, White B, Garcia R, Listgarten M. The dentogingival epithelial surface area revisited. J Periodontal Res 2001; 36: 48-55.
59. Dorn BR, Dunn WA, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 1999; 67: 5792-5798.
60. Deng H, et al. Invasion of four common periodontal pathogens into vascular endothelial cells in vitro. Chinese J Stomatol 2010; 45: 203-206.
61. Roth G, et al. Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J Thromband Haemost 2006; 4: 2256-2261.
62. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994; 14: 133-140.
63. Fiehn N-E, Larsen T, Christiansen N, Holmstrup P, Schroeder TV. Identification of periodontal pathogens in atherosclerotic vessels. J Periodontol 2005; 76: 731-736.
64. Haraszthy V, Zambon J, Trevisan M, Zeid M, Genco R. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71: 1554-1560.
65. Aimetti M, Romano F, Nessi F. Microbiologic analysis of periodontal pockets and carotid atheromatous plaques in advanced chronic periodontitis patients. J Periodontol 2007; 78: 1718-1723.
66. Elter JR, Champagne CM, Offenbacher S, Beck JD. Relationship of periodontal disease and tooth loss to prevalence of coronary heart disease. J Periodontol 2004; 75: 782-790.
67. Lowe G, et al. Total tooth loss and prevalent cardiovascular disease in men and women: possible roles of citrus fruit consumption, vitamin C, and inflammatory and thrombotic variables. J Clin Epidemiol 2003; 56: 694-700.
68. Persson RE, et al. Assessment of periodontal conditions and systemic disease in older subjects. J Clin Periodontol 2002; 29: 803-810.
69. Tonetti MS, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007; 356: 911-920.
70. Elter JR, et al. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 2006; 151: 47.
71. Minassian C, D'Aiuto F, Hingorani AD, Smeeth L. Invasive dental treatment and risk for vascular events response:a self-controlled case series. Ann Intern Med 2010; 153: 499-506.
72. Ide M, et al. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-α, and interleukin-6. J Periodontol 2004; 75: 420-428.
73. D’Aiuto F, Parkar M, Tonetti MS. Periodontal therapy: a novel acute inflammatory model. Inflamm Res 2005; 54: 412-414.
74. D’Aiuto F, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83:156-160.
75. D’aiuto F, Nibali L, Parkar M, Suvan J, Tonetti M. Shortterm effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005; 84: 269-273.
76. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008; 35: 277-290.
77. Pizzo G, Guiglia R, Russo LL, Campisi G. Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept. Eur J Intern Med 2010; 21: 496-502.